-
941
PD-L1/TLR7 dual-targeting nanobody-drug conjugate mediates potent tumor regression via elevating tumor immunogenicity in a host-expressed PD-L1 bias-dependent way
Published 2022-10-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
942
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types
Published 2024-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
943
Anti-PD-1 amplifies costimulation in melanoma-infiltrating Th1-like Foxp3+ regulatory T cells to alleviate local immunosuppression
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
944
Glut3 overexpression improves environmental glucose uptake and antitumor efficacy of CAR-T cells in solid tumors
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
945
Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
946
CD47/SIRPα axis: bridging innate and adaptive immunity
Published 2022-07-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
947
Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
948
Durvalumab and tremelimumab in combination with metronomic oral vinorelbine for recurrent advanced cervical cancer: an open-label phase I/II study
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
949
High peripheral T cell diversity is associated with lower risk of toxicity and superior response to dual immune checkpoint inhibitor therapy in patients with metastatic NSCLC
Published 2024-12-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
950
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
951
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
Published 2023-08-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
952
Association of age, race, and ethnicity with access, response, and toxicities from CAR-T therapy in children and adults with B-cell malignancies: a review
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
953
Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
954
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
955
Knowledge, attitude, practices, and associated factors toward cervical cancer among female health sciences students of Addis Ababa University, Addis Ababa, Ethiopia
Published 2025-01-01“…Therapeutic Advances in Vaccines and Immunotherapy…”
Get full text
Article -
956
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
957
Generation of novel oncolytic vaccinia virus with improved intravenous efficacy through protection against complement-mediated lysis and evasion of neutralization by vaccinia virus...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
958
Human blood cell transcriptomics unveils dynamic systemic immune modulation along colorectal cancer progression
Published 2024-11-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
959
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
960
Clinical significance of plasma-free amino acids and tryptophan metabolites in patients with non-small cell lung cancer receiving PD-1 inhibitor: a pilot cohort study for developin...
Published 2022-05-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article